Pramirise 0.75mg Tablet

Tablet
Rs.105for 1 strip(s) (10 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Pramirise 0.75mg Tablet

Pramipexole(0.75mg)

food interaction for Pramirise Tablet

alcohol interaction for Pramirise Tablet

pregnancy interaction for Pramirise Tablet

lactation interaction for Pramirise Tablet

food
alcohol
pregnancy
lactation
Pramirise 0.75mg Tablet is to be taken with food.
None
CAUTION
Pramirise 0.75mg Tablet may cause excessive drowsiness with alcohol.
UNSAFE
Pramirise 0.75mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Pramirise 0.75mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pramirise 0.75mg Tablet suppresses serum prolactin and may interfere with breastfeeding.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Pramirise 0.75mg Tablet

Pramipexole(0.75mg)

Pramirise tablet uses

{med_name} is used in the treatment of Parkinson's disease and restless leg syndrome.

How pramirise tablet works

Pramirise 0.75mg Tablet works by mimicking the action of dopamine, a chemical messenger that is needed to control movement in the brain.

Common side effects of pramirise tablet

Dizziness, Sleepiness, Nausea, Dryness in mouth, Fatigue, Hallucination, Constipation, Peripheral edema, Muscle spasm

SUBSTITUTES FOR Pramirise Tablet

No substitutes found

Expert advice FOR Pramirise Tablet

  • You have been prescribed Pramipexole to treat your symptoms of Parkinson's disease and/or restless leg syndrome.
  • It can be taken with or without food. Taking it with food may reduce nausea.
  • For restless leg syndrome, take this medicine 2 to 3 hours before bedtime.
  • Avoid activities that require you to be alert, such as driving a car until you know how this medication affects you.
  • When you first start taking Pramipexole, it may cause sudden drop in your blood pressure when you change positions. To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
  • Talk to your doctor in case you develop hallucinations or other changes in your behavior.
  • Inform your doctor if you develop compulsive behaviors that are hard to control, such as binge eating, gambling, spending money, and sexual urges.
  • Do not stop taking the medication suddenly without talking to your doctor.

Frequently asked questions FOR Pramirise 0.75mg Tablet

Pramipexole

Q. Does Pramirise 0.75mg Tablet cause weight gain?
A common side effect of Pramirise 0.75mg Tablet is decrease in body weight which may be due to decrease in appetite. Uncommonly, it can also cause increase in weight. However, if you have concerns regarding your weight talk to your doctor or a nutritionist.
Q. Does Pramirise 0.75mg Tablet make you sleepy?
Yes, Pramirise 0.75mg Tablet may cause sleepiness. You may also experience sudden episodes of falling asleep. If it occurs, restrict driving and using heavy machinery and inform your doctor.
Q. How does Pramirise 0.75mg Tablet work for restless legs?
Restless leg syndrome (RLS) is a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down. Pramirise 0.75mg Tablet belongs to dopamine (neurotransmitter) agonist class of medicines. It acts by stimulating the dopamine receptors which is needed in the brain to control movement. Hence, it is used to improve RLS.
Show More
Q. Is Pramirise 0.75mg Tablet a muscle relaxant?
No, Pramirise 0.75mg Tablet is not a muscle relaxant. It helps in improving movements and muscle control in Parkinson’s disease. It is a dopamine agonist and acts on dopamine receptors.
Q. Can I stop taking Pramirise 0.75mg Tablet if my symptoms of Parkinson’s disease have improved?
You should not stop Pramirise 0.75mg Tablet without talking to your doctor. Sudden discontinuation of Pramirise 0.75mg Tablet may cause neuroleptic malignant syndrome. The symptoms of malignant syndrome include loss of muscle movement, rigid muscles, fever, unstable blood pressure, increased heart rate, confusion, and depressed level of consciousness.
Q. How should Pramirise 0.75mg Tablet be taken?
You should take Pramirise 0.75mg Tablet as directed by your doctor. The doctor will decide your dose depending on the condition you are being treated for. Preferably it should be taken 2-3 hours before bedtime. Swallow the tablets whole with water. It can be taken with or without food, but taking it with food may help reduce the chances of nausea.
Q. What are the serious side effects of Pramirise 0.75mg Tablet?
The serious side effects of Pramirise 0.75mg Tablet include hallucinations (seeing things or hearing voices that do not exist), confusion, aggressive behavior, agitation, abnormal thoughts, changes in vision, abnormal body movements, and motions that you cannot control. It may also cause changes in the way you sit or stand that you cannot control, such as your neck bending forward, bending forward at the waist, or tilting sideways when you sit, stand or walk. Additionally, it may cause dark, red or cola-colored urine, muscle tenderness, muscle stiffness or aching and muscle weakness. Call your doctor immediately if you experience any of these.
Q. What are impulse control disorders caused by Pramirise 0.75mg Tablet?
Pramirise 0.75mg Tablet may cause impulse control disorders in which you may have cravings or urge to behave in an unusual manner, which normally you would not do. Pramirise 0.75mg Tablet may also make it hard for you to resist the impulse to carry certain activities which can harm you or others, like addictive gambling, excessive eating or spending money. Along with that, it may cause an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings.

Content on this page was last updated on 09 September, 2024, by Dr. Varun Gupta (MD Pharmacology)